These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 17110957

  • 1. Inhibition of urokinase-type plasminogen activator receptor induces apoptosis in melanoma cells by activation of p53.
    Besch R, Berking C, Kammerbauer C, Degitz K.
    Cell Death Differ; 2007 Apr; 14(4):818-29. PubMed ID: 17110957
    [Abstract] [Full Text] [Related]

  • 2. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A, Xue M, Jackson C, Smith RC.
    Int J Biochem Cell Biol; 2009 Apr; 41(8-9):1731-8. PubMed ID: 19433314
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H, Okada Y, Funahashi H, Matsuo Y, Takahashi H, Takeyama H, Manabe T.
    BMC Cell Biol; 2006 Feb 20; 7():8. PubMed ID: 16504015
    [Abstract] [Full Text] [Related]

  • 4. Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells.
    Nip J, Rabbani SA, Shibata HR, Brodt P.
    J Clin Invest; 1995 May 20; 95(5):2096-103. PubMed ID: 7537755
    [Abstract] [Full Text] [Related]

  • 5. Urokinase-type plasminogen activator receptor regulates apoptotic sensitivity of colon cancer HCT116 cell line to TRAIL via JNK-p53 pathway.
    Liu X, Qiu F, Liu Z, Lan Y, Wang K, Zhou PK, Wang Y, Hua ZC.
    Apoptosis; 2014 Oct 20; 19(10):1532-44. PubMed ID: 25113506
    [Abstract] [Full Text] [Related]

  • 6. Up-regulation of Mcl-1 is critical for survival of human melanoma cells upon endoplasmic reticulum stress.
    Jiang CC, Lucas K, Avery-Kiejda KA, Wade M, deBock CE, Thorne RF, Allen J, Hersey P, Zhang XD.
    Cancer Res; 2008 Aug 15; 68(16):6708-17. PubMed ID: 18701495
    [Abstract] [Full Text] [Related]

  • 7. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.
    Lee DH, Yang Y, Lee SJ, Kim KY, Koo TH, Shin SM, Song KS, Lee YH, Kim YJ, Lee JJ, Choi I, Lee JH.
    Cancer Res; 2003 Aug 01; 63(15):4648-55. PubMed ID: 12907645
    [Abstract] [Full Text] [Related]

  • 8. MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells.
    Bessard A, Frémin C, Ezan F, Coutant A, Baffet G.
    J Cell Physiol; 2007 Aug 01; 212(2):526-36. PubMed ID: 17427199
    [Abstract] [Full Text] [Related]

  • 9. Focal adhesion kinase promotes the aggressive melanoma phenotype.
    Hess AR, Postovit LM, Margaryan NV, Seftor EA, Schneider GB, Seftor RE, Nickoloff BJ, Hendrix MJ.
    Cancer Res; 2005 Nov 01; 65(21):9851-60. PubMed ID: 16267008
    [Abstract] [Full Text] [Related]

  • 10. An altered fibronectin matrix induces anoikis of human squamous cell carcinoma cells by suppressing integrin alpha v levels and phosphorylation of FAK and ERK.
    Kamarajan P, Kapila YL.
    Apoptosis; 2007 Dec 01; 12(12):2221-31. PubMed ID: 17879163
    [Abstract] [Full Text] [Related]

  • 11. A novel BH3 mimetic reveals a mitogen-activated protein kinase-dependent mechanism of melanoma cell death controlled by p53 and reactive oxygen species.
    Verhaegen M, Bauer JA, Martín de la Vega C, Wang G, Wolter KG, Brenner JC, Nikolovska-Coleska Z, Bengtson A, Nair R, Elder JT, Van Brocklin M, Carey TE, Bradford CR, Wang S, Soengas MS.
    Cancer Res; 2006 Dec 01; 66(23):11348-59. PubMed ID: 17145881
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo.
    Aguirre Ghiso JA.
    Oncogene; 2002 Apr 11; 21(16):2513-24. PubMed ID: 11971186
    [Abstract] [Full Text] [Related]

  • 13. Extracellular signal-regulated kinase and AP-1 pathways are involved in reactive oxygen species-induced urokinase plasminogen activator receptor expression in human gastric cancer cells.
    Kim MH, Cho HS, Jung M, Hong MH, Lee SK, Shin BA, Ahn BW, Jung YD.
    Int J Oncol; 2005 Jun 11; 26(6):1669-74. PubMed ID: 15870884
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of MEK sensitizes human melanoma cells to endoplasmic reticulum stress-induced apoptosis.
    Jiang CC, Chen LH, Gillespie S, Wang YF, Kiejda KA, Zhang XD, Hersey P.
    Cancer Res; 2007 Oct 15; 67(20):9750-61. PubMed ID: 17942905
    [Abstract] [Full Text] [Related]

  • 15. Mitogenic signaling of urokinase receptor-deficient kidney fibroblasts: actions of an alternative urokinase receptor and LDL receptor-related protein.
    Zhang G, Cai X, López-Guisa JM, Collins SJ, Eddy AA.
    J Am Soc Nephrol; 2004 Aug 15; 15(8):2090-102. PubMed ID: 15284295
    [Abstract] [Full Text] [Related]

  • 16. Haemostatic factors occupy new territory: the role of the urokinase receptor system and kininogen in inflammation.
    Chavakis T, Kanse SM, May AE, Preissner KT.
    Biochem Soc Trans; 2002 Apr 15; 30(2):168-73. PubMed ID: 12023845
    [Abstract] [Full Text] [Related]

  • 17. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
    Shin DY, Kim GY, Kim ND, Jung JH, Kim SK, Kang HS, Choi YH.
    Oncol Rep; 2008 Feb 15; 19(2):517-26. PubMed ID: 18202802
    [Abstract] [Full Text] [Related]

  • 18. Functional analysis of the p53 pathway in response to ionizing radiation in uveal melanoma.
    Sun Y, Tran BN, Worley LA, Delston RB, Harbour JW.
    Invest Ophthalmol Vis Sci; 2005 May 15; 46(5):1561-4. PubMed ID: 15851551
    [Abstract] [Full Text] [Related]

  • 19. Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis.
    Chetoui N, Sylla K, Gagnon-Houde JV, Alcaide-Loridan C, Charron D, Al-Daccak R, Aoudjit F.
    Mol Cancer Res; 2008 Jan 15; 6(1):42-52. PubMed ID: 18234961
    [Abstract] [Full Text] [Related]

  • 20. 7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway.
    Hsu TS, Chen C, Lee PT, Chiu SJ, Liu HF, Tsai CC, Chao JI.
    Cancer Chemother Pharmacol; 2008 Oct 15; 62(5):799-808. PubMed ID: 18193228
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.